Literature DB >> 17276518

Carrier frequency of the 35delG and A1555G deafness mutations in the Argentinean population. Impact on the newborn hearing screening.

Luis Pablo Gravina1, María Eugenia Foncuberta, Rosaura Caron Estrada, Cristina Barreiro, Lilien Chertkoff.   

Abstract

OBJECTIVE: Hearing loss is a complex multifactorial disorder caused by genetic and environmental factors. The 35delG mutation in the GJB2 gene is the most prevalent mutation in Caucasian patients with genetic sensorineural deafness. The A1555G mutation in the mitochondrial 12S rRNA is the main genetic alteration associated with aminoglycoside-induced deafness. The aim of this study was to evaluate the prevalence of both mutations in general population of Argentina.
METHODS: A total of 712 samples of unrelated healthy blood donors and 330 newborn dried blood spots were studied by PCR-RFLP.
RESULTS: The 35delG mutation was detected in 11/ 712 unrelated blood donors. The carrier frequency found in this sample (1/65) proved to be lower than that found in Southern European countries, mainly Spain and Italy, from where Argentina originally received its major immigration waves. When the populations of Southern Europe were considered altogether, this difference reached statistical significance. The A1555G mutation was not found in any of the 1042 samples tested.
CONCLUSIONS: Taking into account the 35delG carrier frequency found in this study, it could be estimated that 130-160 children with congenital deafness due to mutations in the connexin genes would be born per year in Argentina. In contrast, the mitochondrial mutation A1555G appears to be infrequent in general Argentinean population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276518     DOI: 10.1016/j.ijporl.2006.12.015

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  12 in total

1.  Screening for the mitochondrial A1555G mutation among Egyptian patients with non-syndromic, sensorineural hearing loss.

Authors:  Mahmoud R Fassad; Lubna M Desouky; Samir Asal; Ebtesam M Abdalla
Journal:  Int J Mol Epidemiol Genet       Date:  2014-12-15

2.  Identification of four novel connexin 26 mutations in non-syndromic deaf patients: genotype-phenotype analysis in moderate cases.

Authors:  Viviana Dalamón; M Florencia Wernert; Vanesa Lotersztein; Patricio O Craig; Raúl Reynoso Diamante; María E Barteik; Carlos Curet; Bibiana Paoli; Enrique Mansilla; Ana Belén Elgoyhen
Journal:  Mol Biol Rep       Date:  2013-10-25       Impact factor: 2.316

3.  The prevalence of mitochondrial mutations associated with aminoglycoside-induced deafness in ethnic Latvian population: the appraisal of the evidence.

Authors:  Viktorija Igumnova; Lauma Veidemane; Anda Vīksna; Valentina Capligina; Egija Zole; Renate Ranka
Journal:  J Hum Genet       Date:  2018-12-06       Impact factor: 3.172

4.  Absence of GJB2 gene mutations, the GJB6 deletion (GJB6-D13S1830) and four common mitochondrial mutations in nonsyndromic genetic hearing loss in a South African population.

Authors:  Rosemary I Kabahuma; Xiaomei Ouyang; Li Lin Du; Denise Yan; Tim Hutchin; Michele Ramsay; Claire Penn; Xue-Zhong Liu
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2011-03-09       Impact factor: 1.675

Review 5.  Genetic etiology of non-syndromic hearing loss in Latin America.

Authors:  Karina Lezirovitz; Regina Célia Mingroni-Netto
Journal:  Hum Genet       Date:  2021-10-15       Impact factor: 4.132

6.  Investigation of the A1555G mutation in mitochondrial DNA (MT-RNR1) in groups of Brazilian individuals with nonsyndromic deafness and normal-hearing.

Authors:  Karina Bezerra Salomão; Christiane Maria Ayo; Valter Augusto Della-Rosa
Journal:  Indian J Hum Genet       Date:  2013-01

Review 7.  A meta-analysis and systematic review of the prevalence of mitochondrially encoded 12S RNA in the general population: Is there a role for screening neonates requiring aminoglycosides?

Authors:  Titus S Ibekwe; Sanjiv K Bhimrao; Brian D Westerberg; Frederick K Kozak
Journal:  Afr J Paediatr Surg       Date:  2015 Apr-Jun

8.  EMQN Best Practice guidelines for diagnostic testing of mutations causing non-syndromic hearing impairment at the DFNB1 locus.

Authors:  Lies H Hoefsloot; Anne-Françoise Roux; Maria Bitner-Glindzicz
Journal:  Eur J Hum Genet       Date:  2013-05-22       Impact factor: 4.246

9.  A rapid method for detection of five known mutations associated with aminoglycoside-induced deafness.

Authors:  Soraya Bardien; Hannique Human; Tashneem Harris; Gwynneth Hefke; Rene Veikondis; H Simon Schaaf; Lize van der Merwe; John H Greinwald; Johan Fagan; Greetje de Jong
Journal:  BMC Med Genet       Date:  2009-01-13       Impact factor: 2.103

10.  Study of streptomycin-induced ototoxicity: protocol for a longitudinal study.

Authors:  Adebolajo A Adeyemo; Odunayo Oluwatosin; Olayemi O Omotade
Journal:  Springerplus       Date:  2016-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.